Publications by authors named "Ziga Rotar"

Claim this Profile
D
Defining Bath Ankylosing Spondylitis Disease Activity Index Cut-off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis.
Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Mehrdad Shoae Kazemi, Žiga Rotar

ACR Open Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrepancies between routine sacroiliac joint MRI reporting and current expert recommendations in patients with spondyloarthritis.
Anna E F Hadsbjerg, Simon Krabbe, Nora Vladimirova, Adrian Ciurea, Kristyna Bubova, Ziga Rotar

RMD Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries.
Romain Aymon, Denis Mongin, Romain Guemara, Zubeyir Salis, Johan Askling, Ziga Rotar

Arthritis Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacroiliac joint involvement in psoriatic arthritis - MRI, radiographic and clinical findings in 581 European routine care patients.
Nora Vladimirova, Anna Ef Hadsbjerg, Simon Krabbe, Adrian Ciurea, Kristýna Bubová, Ziga Rotar

Arthritis Res Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study.
Stylianos Georgiadis, Daniela Di Giuseppe, Almut Scherer, Merete Lund Hetland, Gareth T Jones, Ziga Rotar

BMC Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between lifestyle factors and outcome of treatment with TNFα inhibitors in axial spondyloarthritis - results from 14 European countries.
Gareth T Jones, Ovidiu Rotariu, Ross MacDonald, Brigitte Michelsen, Bente Glintborg, Ziga Rotar

BMC Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network.
Marion Pons, Stylianos Georgiadis, Merete Lund Hetland, Zohra Faizy Ahmadzay, Simon Rasmussen, Ziga Rotar

J Rheumatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe.
Brigitte Michelsen, Mikkel Østergaard, Michael John Nissen, Adrian Ciurea, Burkhard Möller, Ziga Rotar

Health Policy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis.
Marion Pons, Stylianos Georgiadis, Mikkel Østergaard, Zohra Faizy Ahmadzay, Bente Glintborg, Ziga Rotar

Joint Bone Spine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors.
Pasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, Ronald F van Vollenhoven, Rosemary J Hollick, Ovidiu Rotariu, Ziga Rotar

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis.
Stylianos Georgiadis, Marion Pons, Simon Rasmussen, Merete Lund Hetland, Louise Linde, Ovidiu Rotariu, Ziga Rotar

RMD Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased.
Christos Polysopoulos, Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Almut Scherer, Daniela Di Giuseppe, Ziga Rotar

BMC Med Res Methodol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between adult IgA vasculitis and cancer: a prospective observational study.
Alojzija Hočevar, Vesna Jurčič, Žiga Rotar

Front Med (Lausanne)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of ELISA-comparable moderate and high thresholds for anticardiolipin and anti-β2 glycoprotein I chemiluminescent immunoassays according to the 2023 ACR/EULAR APS classification criteria and evaluation of their diagnostic performance.
Polona Žigon, Nika Boštic, Aleš Ambrožič, Žiga Rotar, Elizabeta Blokar

Clin Chem Lab Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries.
Adrian Ciurea, Seraphina Kissling, Andrea Götschi, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, Ziga Rotar

Arthritis Res Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.
Louise Linde, Stylianos Georgiadis, Lykke M Ørnbjerg, Simon H Rasmussen, Brigitte Michelsen, Ziga Rotar

Arthritis Care Res (Hoboken)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registries.
Lykke M Ørnbjerg, Stylianos Georgiadis, Tore K Kvien, Brigitte Michelsen, Simon Rasmussen, Ziga Rotar

RMD Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey.
Zohra F Ahmadzay, Jette Heberg, Jacob B Jørgensen, Lykke M Ørnbjerg, Mikkel Østergaard, Ziga Rotar, Ovidiu Rotariu

Rheumatol Adv Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - relationship with the reason for withdrawal from the previous treatment.
Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Louise Linde, Lennart Jacobsson, Michael J Nissen, Ziga Rotar

Joint Bone Spine· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Daniela Di Giuseppe, Žiga Rotar

J Rheumatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study.
Sara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, Marion Pons, Brigitte Michelsen, Ziga Rotar

RMD Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular maps of synovial cells in inflammatory arthritis using an optimized synovial tissue dissociation protocol.
Sam G Edalat, Reto Gerber, Miranda Houtman, Janine Lückgen, Rui Lourenço Teixeira, Žiga Rotar

iScience· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.
Lykke M Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon H Rasmussen, Lennart Jacobsson, Ziga Rotar

J Rheumatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.
Sara Nysom Christiansen, Simon Horskjær Rasmussen, Marion Pons, Brigitte Michelsen, Bente Glintborg, Ziga Rotar

Semin Arthritis Rheum· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
Romain Aymon, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Ziga Rotar

Ann Rheum Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis